HomeIndustriesHealthcareGLP-1s Have ‘Wind at Their Back’
00:00
00:00
05:40
GLP-1s Have ‘Wind at Their Back’

GLP-1s Have ‘Wind at Their Back’

Mike Nedelcovych surveys the GLP-1 space after the FDA declared the shortage over, boosting makers like NVO and LLY and hurting compounding pharmacies like HIMS, who will stop offering the drugs. He thinks GLP-1s have the “wind at their back,” but notes that the government may be cracking down on Medicare/Medicaid use of the drugs. However, he says that Medicare expansion would be “icing on the cake.”

Morning Movers

27 Feb 2025

SHARE

ON AIR
education
1:30 am
Your First Trade
replay
5:00 am
Trading 360
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Next Gen Investing
REPLAY
education
8:00 am
Your First Trade
REPLAY
education
8:30 am
Inside the Mind of a Trader
REPLAY
education
9:00 am
Inside the Mind of a Trader
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Your First Trade
REPLAY
education
10:30 am
Your First Trade
REPLAY
11:00 am
Market Overtime
REPLAY
11:30 am
Market Overtime
REPLAY
12:00 pm
Morning Movers
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
education
1:00 am
Your First Trade
REPLAY
ON AIR
education
1:30 am
Your First Trade
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
education
3:00 am
Inside the Mind of a Trader
REPLAY
education
3:30 am
Inside the Mind of a Trader
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor